×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MBOT – microbot medical inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MBOT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/10
10:23 am
mbot
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access [Yahoo! Finance]
Low
Report
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access [Yahoo! Finance]
12/10
10:18 am
mbot
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
Low
Report
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
12/10
08:14 am
mbot
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System [Yahoo! Finance]
Low
Report
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System [Yahoo! Finance]
12/10
08:00 am
mbot
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
Medium
Report
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
10/15
11:21 am
mbot
Microbot Medical completes human clinical trial in its ACCESS-PVI [Seeking Alpha]
Medium
Report
Microbot Medical completes human clinical trial in its ACCESS-PVI [Seeking Alpha]
10/15
08:40 am
mbot
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 [Yahoo! Finance]
Medium
Report
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 [Yahoo! Finance]
10/15
08:38 am
mbot
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
Low
Report
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
9/30
08:30 am
mbot
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
Medium
Report
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/19
05:00 pm
mbot
Form 8-K Microbot Medical Inc. For: Dec 17
Medium
Report
Form 8-K Microbot Medical Inc. For: Dec 17
12/10
08:06 am
mbot
Form 424B3 Microbot Medical Inc.
Low
Report
Form 424B3 Microbot Medical Inc.
12/10
08:06 am
mbot
Form 424B3 Microbot Medical Inc.
Low
Report
Form 424B3 Microbot Medical Inc.
12/10
08:00 am
mbot
Form 8-K Microbot Medical Inc. For: Dec 10
Medium
Report
Form 8-K Microbot Medical Inc. For: Dec 10
11/13
04:16 pm
mbot
Form 10-Q Microbot Medical Inc. For: Sep 30
Medium
Report
Form 10-Q Microbot Medical Inc. For: Sep 30
11/6
09:03 am
mbot
Form DEFA14A Microbot Medical Inc.
Low
Report
Form DEFA14A Microbot Medical Inc.
11/6
09:02 am
mbot
Form ARS Microbot Medical Inc. For: Dec 31
Low
Report
Form ARS Microbot Medical Inc. For: Dec 31
11/6
09:00 am
mbot
Form DEF 14A Microbot Medical Inc. For: Nov 06
Low
Report
Form DEF 14A Microbot Medical Inc. For: Nov 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/23
Microbot Medical to Unveil World’s First Fully Disposable Robotic System for Endovascular Procedures
74.9%
9/5 Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference 41.2%
12/24 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, up previously from $10.00. 23.1%
2/21 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 16.9%
1/2 Form SC 13D/A Microbot Medical Inc. Filed by: Gadot Harel 12.5%
12/26 Form 4 Microbot Medical Inc. For: Dec 23 Filed by: Gadot Harel 11.3%
3/17 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.4%
9/11 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock. 5.6%
10/30 Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform 5.1%
7/22 Microbot Medical Inc (NASDAQ: MBOT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.0%
9/5 Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference 41.2%
12/24 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, up previously from $10.00. 23.1%
2/21 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 16.9%
1/2 Form SC 13D/A Microbot Medical Inc. Filed by: Gadot Harel 12.5%
12/26 Form 4 Microbot Medical Inc. For: Dec 23 Filed by: Gadot Harel 11.3%
3/17 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.4%
9/11 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock. 5.6%
10/30 Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform 5.1%
7/22 Microbot Medical Inc (NASDAQ: MBOT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.0%
TOP News Decliners
12/27
Form 424B5 Microbot Medical Inc.
-24.0%
12/26 Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -21.5%
12/30 Microbot Medical Inc. Announces $10.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -16.9%
9/10 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.3%
1/13 Form 8-K Microbot Medical Inc. For: Jan 13 -14.6%
4/1 Microbot Medical Appoints Aileen Stockburger to the Board of Directors -11.5%
12/11 Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers [Seeking Alpha] -10.9%
12/31 Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock -8.0%
10/30 Form 8-K Microbot Medical Inc. For: Oct 30 -7.5%
5/1 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $26.00. -7.0%
12/26 Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -21.5%
12/30 Microbot Medical Inc. Announces $10.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -16.9%
9/10 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.3%
1/13 Form 8-K Microbot Medical Inc. For: Jan 13 -14.6%
4/1 Microbot Medical Appoints Aileen Stockburger to the Board of Directors -11.5%
12/11 Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers [Seeking Alpha] -10.9%
12/31 Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock -8.0%
10/30 Form 8-K Microbot Medical Inc. For: Oct 30 -7.5%
5/1 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $26.00. -7.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: